LGND

286.8500.03%
MJ

Melanie J. Herman

Executive Director of Investor Relations and Financial Planning & Analysis

Ms. Melanie J. Herman, C.P.A, is Executive Director of Investor Relations and Financial Planning & Analysis of Ligand Pharmaceuticals Incorporated. She served as the Chief Accounting Officer of Ligand Pharmaceuticals Incorporated since April 9, 2014 until September 20, 2016 and served as its Interim Chief Financial Officer from May 21, 2015 to August 6, 2015. Ms. Herman joined Ligand Pharmaceuticals in January 2011 and served as its Controller and also Director of Accounting since March 2014. Previously she was Controller at CyDex Pharmaceuticals, Inc. from 2009 to 2011, Assistant Controller and Accounting Manager at Entertainment Properties Trust from 2004 to 2009 and Senior Accountant at KPMG, LLP from 2001 to 2004. Ms. Herman holds a BA with a dual major of Accounting and Finance from Kansas State University and is a Certified Public Accountant.

Positions